KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Capital Expenditures (2020 - 2025)

LifeMD's Capital Expenditures history spans 6 years, with the latest figure at -$6.6 million for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 220.14% year-over-year to -$6.6 million; the TTM value through Dec 2025 reached $1.9 million, down 72.24%, while the annual FY2025 figure was $1.9 million, 72.24% down from the prior year.
  • Capital Expenditures reached -$6.6 million in Q4 2025 per LFMD's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $6.2 million in Q3 2023 to a low of -$6.6 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $868282.2, with a median of $148901.5 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: crashed 10335.01% in 2022, then surged 14058.03% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at -$61105.0 in 2021, then plummeted by 10335.01% to -$6.4 million in 2022, then skyrocketed by 133.05% to $2.1 million in 2023, then surged by 159.73% to $5.5 million in 2024, then plummeted by 220.14% to -$6.6 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Capital Expenditures are -$6.6 million (Q4 2025), $2.8 million (Q3 2025), and $5.5 million (Q2 2025).